STINAG Stuttgart Invest AG (STG) - Net Assets
Based on the latest financial reports, STINAG Stuttgart Invest AG (STG) has net assets worth €145.81 Million EUR (≈ $170.47 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€320.16 Million ≈ $374.30 Million USD) and total liabilities (€174.35 Million ≈ $203.83 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check STINAG Stuttgart Invest AG (STG) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €145.81 Million |
| % of Total Assets | 45.54% |
| Annual Growth Rate | -1.54% |
| 5-Year Change | -2.37% |
| 10-Year Change | N/A |
| Growth Volatility | 1.89 |
STINAG Stuttgart Invest AG - Net Assets Trend (2019–2024)
This chart illustrates how STINAG Stuttgart Invest AG's net assets have evolved over time, based on quarterly financial data. See defensive interval ratio of STINAG Stuttgart Invest AG to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for STINAG Stuttgart Invest AG (2019–2024)
The table below shows the annual net assets of STINAG Stuttgart Invest AG from 2019 to 2024. For live valuation and market cap data, see market cap of STINAG Stuttgart Invest AG.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €149.61 Million ≈ $174.91 Million |
-1.12% |
| 2023-12-31 | €151.31 Million ≈ $176.89 Million |
+0.02% |
| 2022-12-31 | €151.27 Million ≈ $176.85 Million |
-0.75% |
| 2021-12-31 | €152.41 Million ≈ $178.19 Million |
-0.54% |
| 2020-12-31 | €153.24 Million ≈ $179.15 Million |
-5.22% |
| 2019-12-31 | €161.69 Million ≈ $189.03 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to STINAG Stuttgart Invest AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 10.1% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €109.44 Million | 73.25% |
| Other Components | €39.96 Million | 26.75% |
| Total Equity | €149.41 Million | 100.00% |
STINAG Stuttgart Invest AG Competitors by Market Cap
The table below lists competitors of STINAG Stuttgart Invest AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Can2 Termik AS
IS:CANTE
|
$230.47 Million |
|
Indoco Remedies Limited
NSE:INDOCO
|
$230.50 Million |
|
Starz Entertainment LLC
NASDAQ:STRZ
|
$230.69 Million |
|
Fulcrum Therapeutics Inc
NASDAQ:FULC
|
$230.90 Million |
|
Gladiator Metals Corp
V:GLAD
|
$230.24 Million |
|
Vine Hill Capital Investment Corp. II Class A Ordinary Shares
NASDAQ:VHCP
|
$230.23 Million |
|
Dynamix Corporation Unit
NASDAQ:DYNXU
|
$230.20 Million |
|
Arad Investment & Industrial Development Ltd
TA:ARAD
|
$230.14 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in STINAG Stuttgart Invest AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 151,092,000 to 149,406,000, a change of -1,686,000 (-1.1%).
- Net income of 5,252,000 contributed positively to equity growth.
- Dividend payments of 7,145,000 reduced retained earnings.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €5.25 Million | +3.52% |
| Dividends Paid | €7.14 Million | -4.78% |
| Other Changes | €207.00K | +0.14% |
| Total Change | €- | -1.12% |
Book Value vs Market Value Analysis
This analysis compares STINAG Stuttgart Invest AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.46x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 1.36x to 1.46x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | €10.84 | €14.70 | x |
| 2020-12-31 | €10.28 | €14.70 | x |
| 2021-12-31 | €10.22 | €14.70 | x |
| 2022-12-31 | €10.15 | €14.70 | x |
| 2023-12-31 | €10.15 | €14.70 | x |
| 2024-12-31 | €10.04 | €14.70 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently STINAG Stuttgart Invest AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 3.52%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 18.29%
- • Asset Turnover: 0.09x
- • Equity Multiplier: 2.12x
- Recent ROE (3.52%) is above the historical average (3.38%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 4.42% | 36.94% | 0.08x | 1.52x | €-9.01 Million |
| 2020 | 1.78% | 14.14% | 0.08x | 1.64x | €-12.58 Million |
| 2021 | 2.98% | 21.06% | 0.08x | 1.77x | €-10.68 Million |
| 2022 | 3.39% | 21.03% | 0.08x | 2.09x | €-9.98 Million |
| 2023 | 4.17% | 22.42% | 0.09x | 2.14x | €-8.81 Million |
| 2024 | 3.52% | 18.29% | 0.09x | 2.12x | €-9.69 Million |
Industry Comparison
This section compares STINAG Stuttgart Invest AG's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| STINAG Stuttgart Invest AG (STG) | €145.81 Million | 4.42% | 1.20x | $230.35 Million |
| Covestro AG (1COV) | $5.64 Billion | 8.13% | 1.29x | $11.10 Billion |
| 2invest AG (2INV) | $48.10 Million | -5.52% | 0.29x | $70.69 Million |
| COINSHARES I. LS-000247 (3TW) | $269.95 Million | -1206.08% | 19.01x | $472.53 Million |
| Adaptimmune Therapeutics plc (473A) | $246.88 Million | -38.69% | 0.12x | $42.94 Million |
| KINGMAN MINERALS LTD. (47A) | $1.72 Million | -14.34% | 0.35x | $332.43K |
| GENOR BIOPHARMA DL-00002 (67N0) | $1.19 Billion | -56.64% | 0.22x | $118.37 Million |
| Biotest Aktiengesellschaft (BIO) | $476.90 Million | -0.99% | 1.32x | $976.15 Million |
| Biotest Aktiengesellschaft (BIO3) | $476.90 Million | -0.99% | 1.32x | $656.94 Million |
| Bancolombia S.A (BXK) | $33.93 Trillion | 12.05% | 7.54x | $4.84 Billion |
| mVISE AG (C1V) | $2.64 Million | -58.21% | 1.04x | $10.43 Million |
About STINAG Stuttgart Invest AG
STINAG Stuttgart Invest AG, through its subsidiaries, engages in the real estate business in Germany. Its real estate portfolio includes commercial buildings, offices, hotels, micro-apartments, production, senior living and care property, and apartments. The company was incorporated in 1872 and is based in Stuttgart, Germany. STINAG Stuttgart Invest AG operates as a subsidiary of Brasserie-Holdin… Read more